These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21978848)

  • 1. The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis.
    Huang XN; Fu J; Wang WZ
    J Neuroimmunol; 2011 Oct; 239(1-2):61-7. PubMed ID: 21978848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor.
    Yu JZ; Ding J; Ma CG; Sun CH; Sun YF; Lu CZ; Xiao BG
    J Neurosci Res; 2010 Jun; 88(8):1664-72. PubMed ID: 20077431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of a novel Rho kinase inhibitor WAR-5 in experimental autoimmune encephalomyelitis by modulating inflammatory response and neurotrophic factors.
    Li YH; Yu JZ; Xin YL; Feng L; Chai Z; Liu JC; Zhang HZ; Zhang GX; Xiao BG; Ma CG
    Exp Mol Pathol; 2015 Oct; 99(2):220-8. PubMed ID: 26112093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.
    Chen C; Yu JZ; Zhang Q; Zhao YF; Liu CY; Li YH; Yang WF; Ma CG; Xiao BG
    Neuromolecular Med; 2015 Dec; 17(4):454-65. PubMed ID: 26481340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of Rho kinase inhibitor fasudil derivative FaD-1 in experimental autoimmune encephalomyelitis.
    Zhao YF; Zhang X; Ding ZB; Yang XW; Zhang H; Yu JZ; Li YH; Liu CY; Zhang Q; Zhang HZ; Ma CG; Xiao BG
    J Mol Neurosci; 2015 Mar; 55(3):725-32. PubMed ID: 25223373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
    Liu C; Li Y; Yu J; Feng L; Hou S; Liu Y; Guo M; Xie Y; Meng J; Zhang H; Xiao B; Ma C
    PLoS One; 2013; 8(2):e54841. PubMed ID: 23418431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms.
    Yan Y; Yu J; Gao Y; Kumar G; Guo M; Zhao Y; Fang Q; Zhang H; Yu J; Jiang Y; Zhang HT; Ma CG
    Metab Brain Dis; 2019 Apr; 34(2):377-384. PubMed ID: 30552558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis.
    Sun X; Minohara M; Kikuchi H; Ishizu T; Tanaka M; Piao H; Osoegawa M; Ohyagi Y; Shimokawa H; Kira J
    J Neuroimmunol; 2006 Nov; 180(1-2):126-34. PubMed ID: 16996142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.
    Aubé B; Lévesque SA; Paré A; Chamma É; Kébir H; Gorina R; Lécuyer MA; Alvarez JI; De Koninck Y; Engelhardt B; Prat A; Côté D; Lacroix S
    J Immunol; 2014 Sep; 193(5):2438-54. PubMed ID: 25049355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
    Li YH; Yu JZ; Liu CY; Zhang H; Zhang HF; Yang WF; Li JL; Feng QJ; Feng L; Zhang GX; Xiao BG; Ma CG
    Immunology; 2014 Oct; 143(2):219-29. PubMed ID: 24749492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
    Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
    J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis.
    Pineda AA; Minohara M; Kawamura N; Matsushita T; Yamasaki R; Sun X; Piao H; Shimokawa H; Kira J
    J Neurol Sci; 2011 Jul; 306(1-2):115-20. PubMed ID: 21501850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
    Bennett J; Basivireddy J; Kollar A; Biron KE; Reickmann P; Jefferies WA; McQuaid S
    J Neuroimmunol; 2010 Dec; 229(1-2):180-91. PubMed ID: 20832870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between aquaporin-4 expression and blood-brain and spinal cord barrier permeability following experimental autoimmune encephalomyelitis in the rat.
    Huang XN; Wang WZ; Fu J; Wang HB
    Anat Rec (Hoboken); 2011 Jan; 294(1):46-54. PubMed ID: 21157915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis.
    Daniel PM; Lam DK; Pratt OE
    J Neurol Sci; 1981; 52(2-3):211-9. PubMed ID: 6796652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROCK inhibitor abolishes the antibody response in experimental autoimmune myasthenia gravis.
    Li H; Zhang M; Wang CC; Li XL; Zhang P; Yue LT; Miao S; Dou YC; Li YB; Duan RS
    Mol Cell Neurosci; 2016 Jul; 74():106-13. PubMed ID: 27168379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Fasudil on miroglia and astrocytes in experimental autoimmune encephalomyelitis mice].
    Li YH; Liu CY; Zhang PJ; Yu JZ; Ji N; Yan YY; Feng L; Zhang HF; Xiao BG; Ma CG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1242-5. PubMed ID: 23232512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of liposome brain localization in rat experimental allergic encephalomyelitis.
    Rousseau V; Denizot B; Le Jeune JJ; Jallet P
    Exp Brain Res; 1999 Apr; 125(3):255-64. PubMed ID: 10229016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fasudil, a selective inhibitor of Rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma.
    Impellizzeri D; Mazzon E; Paterniti I; Esposito E; Cuzzocrea S
    J Pharmacol Exp Ther; 2012 Oct; 343(1):21-33. PubMed ID: 22733360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
    Stohl W; Gonatas NK
    J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.